MarketGrader Developed Markets (ex-US) Health Care Index


Five Largest Companies
Symbol Name Grade Market Cap Country
GSK.GB GSK plc 49.9 ¤79,666 GB
7741.JP HOYA CORPORATION 63.6 ¤46,093 JP
4578.JP Otsuka Holdings Co., Ltd. 49.5 ¤31,787 JP
068270.KR Celltrion, Inc. 35.6 ¤28,453 KR
7733.JP Olympus Corp. 40.0 ¤21,856 JP

Five Smallest Companies
Symbol Name Grade Market Cap Country
4552.JP JCR Pharmaceuticals Co., Ltd. 38.6 ¤567 JP
COP.DE CompuGroup Medical SE & Co. KGaA 37.1 ¤758 DE
3613.HK Beijing Tong Ren Tang Chinese Medicine C 34.8 ¤863 HK
CVSG.GB CVS Group plc 35.2 ¤905 GB
7071.JP Amvis Holdings.Inc. 74.9 ¤1,240 JP

Companies with Most Selections Among Current Components
Symbol Name Grade Times* Country
4507.JP Shionogi & Co., Ltd. 48.9 20 JP
GSK.GB GSK plc 49.9 20 GB
IPN.FR Ipsen SA 65.0 18 FR
1093.HK CSPC Pharmaceutical Group Limited 53.6 16 CN
6849.JP Nihon Kohden Corporation 35.0 15 JP
4528.JP ONO Pharmaceutical Co., Ltd. 60.5 14 JP
4578.JP Otsuka Holdings Co., Ltd. 49.5 14 JP
7741.JP HOYA CORPORATION 63.6 13 JP
4516.JP Nippon Shinyaku Co., Ltd. 70.4 10 JP
SFZN.CH Siegfried Holding AG 58.5 9 CH
*Number of times selected at Index semi-annual reconstitutions since inception date.
Index Bio
Average Market Cap ¤0
Median Market Cap ¤0
Avg. 3 Mo. Dollar Vol. ¤0
Avg. 3 Mo. Trading Vol. 0
Last Rebalance Date N/A
Companies Replaced
Biggest Increase
Biggest Decrease

Fundamental Attributes
Trailing P/E Ratio (12 Mo.) 0.0
Forward P/E Ratio (12 Mo.) 0.0
Price/Book Ratio 0.0
Avg. Revenue Chg. - 3 Yr 0.0%
Avg. Op. Income Chg. - 3 Yr. 0.0%
Avg. EPS Growth - 3 Yr. 0.0%
Avg. EPS Growth - 1 Yr. 0.0%
Avg. Operating Margin 0.0%
Avg. LT Debt to Total Capital 0.0%
Avg. Return on Equity 0.0%
Dividend Yield 0%
Index Average Grade
0.0
Country Breakdown
Japan 46.67%
Korea, Republic Of 10.0%
Taiwan, Province Of China 6.67%
United Kingdom 6.67%
Hong Kong 6.67%
Italy 3.33%
Switzerland 3.33%
China 3.33%
Germany 3.33%
Denmark 3.33%
Spain 3.33%
France 3.33%
For more information on this index please contact us

Get Access to the World's Smartest Global Research Platform

Don't wait another day to make better informed, higher-returning investments.

TRY IT FOR FREE